ravulizumab
tislelizumab
presentation
gevokizumab
talizumab
antinucleosome
intetumumab
immunocytology
polyvalent
idiospecific
sonepcizumab
immunobinding
specific
autoantibody
soravtansine
immunosorbance
radioimmunodiagnosis
elotuzumab
radioimmunochemistry
serospecific
antisynthetase
tucotuzumab
immunostrip
bococizumab
-les-
miniantibody
radioimmunoelectrophoresis
retifanlimab
zenocutuzumab
toripalimab
lorvotuzumab
affibody
sasanlimab
sintilimab
complement
dinutuximab
immunomolecule
vanucizumab
ziltivekimab
pozelimab
solitomab
radioimmunoprecipitate
radioimmunoreactivity
glembatumumab
active immunity
autoagglutinin
antimonoclonal
autocentromere